Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.
Sci Rep
; 9(1): 14824, 2019 Oct 10.
Article
in En
| MEDLINE
| ID: mdl-31597938
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Sci Rep
Year:
2019
Type:
Article
Affiliation country:
United States